Literature DB >> 8886448

Multidrug resistance associated with overexpression of MRP.

S P Cole1, R G Deeley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886448     DOI: 10.1007/978-1-4613-1267-3_2

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  5 in total

1.  May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?

Authors:  O Turriziani; P Di Marco; G Antonelli; F Dianzani
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.

Authors:  Olivier E Pardo; Adeline Lesay; Alexandre Arcaro; Rita Lopes; Bee Ling Ng; Patricia H Warne; Iain A McNeish; Teresa D Tetley; Nicholas R Lemoine; Huseyin Mehmet; Michael J Seckl; Julian Downward
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters.

Authors:  R V Srinivas; D Middlemas; P Flynn; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

4.  The role of multidrug resistance-associated protein in the blood-brain barrier and opioid analgesia.

Authors:  Wendy Su; Gavril W Pasternak
Journal:  Synapse       Date:  2013-05-02       Impact factor: 2.562

5.  Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs.

Authors:  A Váradi; G E Tusnády; E Bakos; B Sarkadi
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.